The startup Hipper Therapeutics B.V. focuses on the development of a digital platform for the support of professionals and patients in ambulatory geriatric rehabilitation. The platform consists of a system that can measure physical activities of the older person remotely (i.e. in the home environment), a dashboard that visualizes this information and a protocol and training for the professionals. The company has been set up by Margriet Pol from AUAS faculty of health, Ben Kröse and Michel Oey from AUAS faculty of digital media and creative industry, together with HvA Ventures Holding and AMC Ventures Holding.
Margriet Pol, Ben Kröse, Michel Oey from AUAS and Ross Gordon from HvA Ventures
The market for geriatric rehabilitation will grow enormously the coming years, in particular the number of older persons that will rehabilitate in their own home (ambulatory rehabilitation). The last years the platform was developed and studied in a number of research projects at AUAS and AMC after getting questions from care professionals on their concerns about remotely monitoring rehabilitation progress. The Hipper platform empowers therapists because it gives objective information (24 hrs/day, 7 days/week) about the physical activity of their clients. Also clients can login to the platform and see their progress, which in many cases is a motivational factor.
The platform is currently used by a number of geriatric rehabilitation centers for rehabilitation after hip surgery and for elderly with COPD. A very recent development is the use of the Hipper platform for the rehabilitation of COVID-19 patients.
IXA has supported the founders with setting up the company and currenty also in assistance for getting the required certifications on compliance with norms on privacy and data in health.
Fitsurance and how they ‘pivot’ during COVID-19, as a VU ‘personal health’ startup All was lost (well, almost) After a great pilot-project in Zeeland, where we measured runners on the beach, to see what a 3-day running event did with runners’ health, we stepped up our efforts to prepare for 2020, in order to make […]News
Haermonics, een spin-off van Amsterdam UMC, heeft de effectiviteit en veiligheid bewezen van het spoelen van het hartzakje na een openhartoperatie. Een experimentele opstelling zorgde voor significant minder bloedingsgerelateerde complicaties. BOM Brabant Ventures en GAP Technologies investeren in het bedrijf voor de verdere ontwikkeling van de apparatuur en de disposables. Haermonics blijft samenwerken met Amsterdam […]News
This collaboration is part of 2-year UK government-funded project to bring RxSelexTM closer to patients Amsterdam UMC and AlphaBiomics Ltd., a United Kingdom (UK)-based precision medicine company, have initiated a collaboration to personalize care in patients suffering from inflammatory bowel disease (IBD). IBD patient response to biologics therapy is highly variable, with some patients receiving long-term benefits, […]News